IU School of Medicine wins $12.3 million grant for research into opioid addiction treatment

Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.

Published on Thu, 17 Sep 2020 19:01:57 -0400 and delivered to you by salesforce array ends with variable